Envista Holdings (NVST) has just priced a US$430 million issue of 6.250% senior unsecured notes due 2033 at 99.482% of face value, giving equity investors fresh information on the company’s capital structure and funding costs.
Envista Holdings’ recent bond issue follows a busy period that included a third quarter earnings release on 4 November and a shelf registration on 9 November. Over this time, the stock has pulled back, with a 1 week share price return of 6.88% and a 90 day share price return of 9.83%. It still shows a 1 month share price return of 11.44% and a 1 year total shareholder return of 25.84%, indicating momentum that has cooled in the short term while remaining constructive over a longer period.
Spot fresh setups by comparing Envista Holdings’ bond-financed repositioning with other hand picked healthcare names in the 37 healthcare AI stocks.Envista Holdings now trades below both analyst targets and some intrinsic value estimates after this bond funded reset. Where does a reasonable fair value range actually land for the stock today?
Most Popular Narrative: 12.5% Undervalued
On the analyst consensus Narrative on Simply Wall St, Envista Holdings carries a fair value estimate of $28.92 against a last close of $25.32. This frames the new debt issue inside a story that already sees the shares trading below that range and heavily discounts future earnings power using an 8.21% rate.
Sustained execution under the Envista Business System, which management credits with about 300 basis points of margin improvement since 2024, around US$100 million of price realization over three years and several quarters of gross margin expansion, together with free cash flow conversion near 100% and a balance sheet at roughly 0.6 to 0.7x net debt to adjusted EBITDA, supports further productivity gains and capital deployment into R&D, M&A and buybacks that can benefit net margins and EPS.
See why 3 investors see Envista Holdings as 12% undervalued.
Result: Fair Value of $28.92 (UNDERVALUED)
Still, Envista Holdings faces real pressure from China’s volume based procurement cuts, as well as from any prolonged softness in higher ticket orthodontics and implant procedures.
Find out about the key risks to this Envista Holdings narrative.
Next Steps
The mix of risks and rewards around Envista Holdings is already in front of you, so act while the details are still fresh and pressure test the data for yourself with the 3 key rewards and 1 important warning sign.
Looking for more Envista Holdings sized opportunities?
If Envista Holdings has sharpened your thinking, do not stop here. Broaden your watchlist and pressure test fresh ideas before the market moves first.
- Target mispriced quality by reviewing a curated 32 high quality undervalued stocks that already screens for both solid cash flows and balance sheet strength.
- Build a sturdier core by scanning a list of solid balance sheet and fundamentals (23 results) that can help anchor your portfolio when sentiment swings.
- Get ahead of the crowd by studying a 19 high quality undiscovered gems that focuses on strong fundamentals before wider attention arrives.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com